-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
18A
Category | Human immunodeficiency Virus (HIV) |
CAS | 331261-50-8 |
Description | HIV-1 Inhibitor 18A is a reversible broad-spectrum HIV-1 inhibitor. |
Product Information
Synonyms | 331261-50-8;HIV-1 Inhibitor 18A;1-(2,1,3-Benzothiadiazol-4-yl)-3-[(E)-(4-hydroxyphenyl)methyleneamino]urea;1-(2,1,3-benzothiadiazol-4-yl)-3-[(E)-(4-hydroxyphenyl)methylideneamino]urea;18A;N-(Benzo[c][1,2,5]thiadiazol-4-yl)-2-(4-hydroxybenzylidene)hydrazine-1-carboxamide;N-2,1,3-Benzothiadiazol-4-yl-2-[(4-hydroxyphenyl)methylene]hydrazinecarboxamide,;MLS000715119;CHEMBL3196736;SCHEMBL19472586;HMS1683A06;STL444722;AKOS000542277;AKOS040745853;SMR000275098;TS-08366;HY-110253;CS-0033118;SR-01000370382;SR-01000370382-1;(2E)-N-(2,1,3-benzothiadiazol-4-yl)-2-(4-hydroxybenzylidene)hydrazinecarboxamide; |
IUPAC Name | 1-(2,1,3-benzothiadiazol-4-yl)-3-[(E)-(4-hydroxyphenyl)methylideneamino]urea |
Molecular Weight | 349.66 |
Molecular Formula | C14H8ClF4NO3 |
Canonical SMILES | C1=CC(=CC=C1NC(=O)C2=CC(=C(C=C2O)F)Cl)OC(F)(F)F |
InChI | InChI=1S/C14H11N5O2S/c20-10-6-4-9(5-7-10)8-15-17-14(21)16-11-2-1-3-12-13(11)19-22-18-12/h1-8,20H,(H2,16,17,21)/b15-8+ |
InChIKey | QRTYYEYYXURINZ-OVCLIPMQSA-N |
Density | 1.52±0.1 g/cm3 |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |